Ocrelizumab in pediatric patients with MS: Efficacy, tolerability, and safety

被引:0
|
作者
Zeydan, Burcu [1 ]
机构
[1] Mayo Clin, Dept Neurol & Radiol, Rochester, MN 85054 USA
关键词
D O I
10.1016/j.ejpn.2023.03.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A1 / A1
页数:1
相关论文
共 50 条
  • [1] Safety and Efficacy of Fingolimod and Ocrelizumab in Pediatric Patients With Multiple Sclerosis
    Spirek, Benton
    Brenton, J. Nicholas
    PEDIATRIC NEUROLOGY, 2025, 164 : 89 - 96
  • [2] Utilization, safety, and tolerability of ocrelizumab: data from the providence ocrelizumab registry
    Smoot, K.
    Stuchiner, T.
    Grote, L.
    Chen, C.
    Cohan, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 386 - 386
  • [3] Safety, tolerability, and efficacy of orally administered cannabinoids in MS
    Russo, EB
    NEUROLOGY, 2003, 60 (04) : 729 - 729
  • [4] Safety, tolerability, and efficacy of orally administered cannabinoids in MS
    Killestein, J
    Hoogervorst, ELJ
    Reif, M
    Kalkers, NF
    van Loenen, AC
    Staats, PGM
    Gorter, RW
    Uitdehaag, BMJ
    Polman, CH
    NEUROLOGY, 2002, 58 (09) : 1404 - 1407
  • [5] Ziprasidone in pediatric patients: efficacy and tolerability
    MacMillan, C
    Miller, TP
    Hsin, O
    Johnson, F
    Gonzalez-Heydrich, J
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (04) : 519 - 519
  • [6] Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China
    Zhao, Ting
    Li, Hong-jian
    Ma, Long
    Feng, Jie
    Wang, Ting-ting
    Yu, Jing
    Sun, Li
    Sun, Yan
    Yu, Lu-hai
    EPILEPSY & BEHAVIOR, 2021, 117
  • [7] Efficacy, safety and tolerability of meropenem as empiric antibiotic therapy in hospitalized pediatric patients
    Bradley, JS
    Faulkner, KL
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (08) : 749 - 757
  • [8] The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population
    Tekgul, Hasan
    Gencpinar, Pinar
    Cavusoglu, Dilek
    Dundar, Nihal Olgac
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2016, 36 : 16 - 21
  • [9] Safety and tolerability of edasalonexent in pediatric patients with DMD
    Alford, Raye
    GENETICS IN MEDICINE, 2019, 21 (05) : 1030 - 1030
  • [10] Evaluating the efficacy and safety of transitioning patients from natalizumab to ocrelizumab
    Smoot, K.
    Marginean, H.
    Gervasi-Follmar, T.
    Zhang, H. -J.
    Chen, C.
    Repovic, P.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 877 - 877